The Mercodia Glucagon ELISA is a CE/IVD-labelled, highly specific, and sensitive immunoassay for measuring glucagon in plasma and serum. The highly specific monoclonal antibodies used in this assay enable accurate determination of glucagon without significant cross-reactivity to other circulating pro-glucagon-derived peptides.
Mercodia Mouse Insulin ELISA is an easy-to-use assay based on highly specific monoclonal antibodies with insignificant or no cross-reactivity to C-peptide or proinsulin. A highly specific assay for the quantitative determination of insulin in mouse serum or plasma.
Proinsulin ELISA is a method for the quantitative determination of human proinsulin in serum or plasma.
Mercodia Total GLP-1 NL-ELISA provides a chemiluminescent method for the quantitative determination of amidated GLP-1 (1-36) in human serum or plasma samples. The assay has been validated according to CLSI, FDA and EMA guidelines.
The Mercodia Total GIP NL-ELISA provides a method for the quantitative determination of GIP in human samples. Mercodia Total GIP NL-ELISA measures active GIP(1-42) to the same extent as its metabolite GIP(3-42). Thus, the rapid degradation of the active GIP(1-42) form is not a problem for the specificity of the assay. Accurate results are obtained even if samples without any stabilizing additives are analyzed.
Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use. It provides a chemiluminescent method for the quantitative determination of insulin lispro. The kit includes six calibrators, two anchor points and controls in serum matrix. Validation data available.
Tailored bioanalytical services for preclinical to clinical studies, primarily for large molecules, biosimilars, peptides, and oligonucleotides.
A biologically relevant and powerful way to assess CD32/FcyRlla induced effects.
A biologically relevant and powerful way to assess CD32/FcyRlla induced effects.
Aura® GT helps you realize the promise of gene therapies, without using a lot of your viral vector sample throughout the development process. Avoid conditions and formulations that facilitate viral vector aggregates, monitor DNA leakage, and ensure product quality with just 5 µL of sample per data point.
Aura® PTx gets you to your best formulation faster! Backgrounded Imaging (BMI) technology to give you accurate count, size, and morphology information about particles in your sample. Couple that with Fluorescence Membrane Microscopy (FMM), which gives you definitive ID of protein aggregates and an easy way to monitor polysorbate degradation.
The Gyrolab® Human IL-4 Kit Reagents enables rapid quantification of IL-4 in human or cyno serum samples
The Gyrolab® Human IL-6 Kit Reagents enables rapid quantification of IL-6 in human or cyno serum samples
The Gyrolab® Human IFN-gamma Kit Reagents enables rapid quantification of IFN-gamma in human or cyno serum samples
The Gyrolab® Human TNF-alpha Kit Reagents enables rapid quantification of TNF-alpha in human or cyno serum samples
The CHO HCP 3G Solution for Gyrolab is for the detection of CHO host cell protein (HCP) impurities with the CHO HCP 3G Assay Reagent Set for Gyrolab from Cygnus Technologies and the Gyrolab Bioaffy™ 1000 HC Assay Toolbox
ITEX Dynamic Headspace - Rapid and efficient enrichment of volatile and semi-volatile
Stay in contact with your syringes Each Smart syringe is equipped with its own read/write chip with preset parameters, ranges, usage tracking and a unique ID. The syringe is automatically recognized by the PAL System and all important parameters are loaded to secure highest precision and process safety.
With new advances in field of view, sensitivity, wavelength, and sample accommodation, the Ultima 2Pplus delivers an ideal combination of flexibility, resolution, imaging depth and speed, allowing simultaneous imaging, stimulation and electrophysiology protocols with greater efficiency and effectivity. The system is designed specifically for intravital imaging, with fully motorized control of the objective X-Y-Z position, as…
Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.
Discover our breadth of experience and be reassured that our Lateral Flow Development Services will deliver the best outcome for your assay.
BBI Solutions has over 25 years’ expertise working with customers and partners to develop and manufacture high quality proteins for a diverse range of applications with our Custom Protein Service.
BBI’s custom conjugation service allows us to develop high-quality conjugates using reagents provided by you or sourced by us.
BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.
